Profile data is unavailable for this security.
About the company
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
- Revenue in USD (TTM)1.97bn
- Net income in USD375.04m
- Incorporated1997
- Employees8.72k
- LocationAlign Technology Inc2820 Orchard PkwySAN JOSE 95134-2019United StatesUSA
- Phone+1 (408) 470-1000
- Fax+1 (408) 470-1010
- Websitehttp://www.aligntech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steris PLC | 2.73bn | 275.67m | 10.34bn | 12.00k | 37.92 | 3.33 | 20.82 | 3.79 | 3.22 | 3.15 | 31.93 | 36.71 | 0.5372 | 7.14 | 5.56 | 227,494.20 | 5.44 | 4.28 | 5.90 | 4.73 | 41.52 | 40.56 | 10.13 | 6.94 | 1.99 | 8.37 | 0.2859 | 47.97 | 0.2771 | 11.77 | 147.35 | 11.20 | 13.61 | 10.33 |
| Varian Medical Systems, Inc. | 2.98bn | 368.40m | 12.05bn | 7.17k | 33.25 | 7.22 | 27.35 | 4.04 | 3.99 | 3.96 | 32.29 | 18.39 | 0.894 | 3.76 | 3.14 | 415,611.90 | 11.08 | 9.32 | 19.90 | 15.77 | 43.16 | 42.61 | 12.39 | 11.86 | 1.37 | -- | 0.00 | 0.00 | 11.45 | -0.1623 | 58.77 | -3.98 | -8.96 | -- |
| Teleflex Incorporated | 2.40bn | 173.97m | 13.15bn | 14.40k | 75.82 | 5.24 | 34.65 | 5.47 | 3.77 | 1.41 | 52.16 | 54.55 | 0.4043 | 2.65 | 7.06 | 166,796.80 | 2.93 | 5.19 | 3.18 | 5.97 | 56.18 | 52.28 | 7.24 | 11.55 | 1.51 | 3.65 | 0.462 | 26.80 | 14.90 | 6.71 | 10.95 | -- | 1.63 | 0.00 |
| DexCom, Inc. | 914.60m | 148.90m | 13.19bn | 2.29k | 88.13 | 23.45 | 75.99 | 14.42 | 1.68 | 0.4685 | 10.34 | 6.33 | 0.9346 | 6.50 | 6.53 | 399,388.70 | 15.22 | -7.96 | 18.10 | -10.11 | 65.01 | 67.45 | 16.28 | -5.67 | 4.43 | -- | 0.381 | -- | 25.33 | 48.38 | 184.60 | -- | 47.35 | -- |
| Hologic, Inc. | 3.26bn | -431.40m | 13.48bn | 6.25k | -- | 5.17 | 290.00 | 4.14 | -1.55 | -1.50 | 11.87 | 8.96 | 0.4349 | 3.99 | 5.78 | 521,017.30 | -5.76 | 1.97 | -6.85 | 2.29 | 52.38 | 52.88 | -13.24 | 5.42 | 0.9124 | 3.90 | 0.5681 | 0.00 | 5.20 | 5.24 | -160.56 | -- | 3.23 | -- |
| Cooper Companies Inc | 2.53bn | 354.50m | 13.77bn | 12.00k | 39.05 | 4.15 | 21.87 | 5.44 | 7.15 | 2.76 | 51.12 | 67.23 | 0.4617 | 1.95 | 7.33 | 211,066.70 | 6.46 | 6.47 | 7.06 | 7.23 | 64.45 | 62.37 | 14.00 | 14.57 | 1.16 | 4.97 | 0.3795 | 0.9835 | 18.41 | 9.79 | -4.93 | 3.66 | 1.68 | 0.00 |
| ResMed Inc. | 2.45bn | 462.88m | 14.39bn | 5.94k | 31.28 | 7.36 | 24.38 | 5.86 | 3.21 | 3.12 | 17.03 | 13.65 | 0.6613 | 3.45 | 5.11 | 413,239.60 | 12.47 | 13.28 | 16.44 | 15.61 | 58.40 | 59.41 | 18.86 | 19.48 | 1.76 | 29.88 | 0.3797 | 46.18 | 13.23 | 9.09 | 32.52 | 8.11 | -0.0907 | 15.54 |
| ABIOMED, Inc. | 736.79m | 221.30m | 16.32bn | 1.14k | 75.53 | 19.16 | 69.72 | 22.16 | 4.79 | 4.81 | 15.96 | 18.90 | 0.8788 | 2.10 | 9.63 | 644,608.10 | 26.40 | 17.28 | 29.34 | 19.66 | 83.06 | 83.34 | 30.04 | 19.35 | 5.99 | -- | 0.00 | 0.00 | 33.34 | 30.29 | 156.29 | 54.83 | 81.50 | -- |
| IDEXX Laboratories, Inc. | 2.21bn | 377.03m | 18.13bn | 7.60k | 49.33 | -- | 51.23 | 8.19 | 4.26 | 4.26 | 25.02 | -0.1099 | 1.36 | 5.76 | 9.16 | -- | 23.20 | 16.93 | 51.12 | 39.06 | 56.10 | 55.51 | 17.04 | 14.01 | 0.6242 | 14.63 | 1.01 | -- | 12.40 | 9.96 | 28.18 | 14.96 | 9.35 | -- |
| Align Technology, Inc. | 1.97bn | 375.04m | 20.39bn | 8.72k | 55.29 | 16.28 | 63.25 | 10.37 | 4.61 | 4.92 | 24.17 | 15.66 | 1.03 | 11.88 | 5.15 | -- | 20.00 | 17.86 | 29.02 | 24.15 | 73.63 | 75.06 | 19.51 | 19.73 | 1.80 | -- | -- | -- | 33.47 | 24.39 | 26.77 | 44.15 | -- | -- |
| Zimmer Biomet Holdings Inc | 7.93bn | -408.10m | 25.22bn | 18.20k | -- | 2.24 | 39.89 | 3.18 | -2.01 | -1.87 | 38.76 | 55.28 | 0.3164 | 1.06 | 5.63 | -- | -1.63 | 1.22 | -1.83 | 1.35 | 71.03 | 71.20 | -5.15 | 3.82 | 0.9059 | 5.36 | 0.4422 | 69.70 | 1.39 | 11.40 | -175.38 | -- | 8.43 | 3.71 |
Data as of Feb 15 2019. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD
35.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2018 | 7.90m | 9.88% |
| BlackRock Fund Advisorsas of 31 Dec 2018 | 3.88m | 4.85% |
| Sands Capital Management LLCas of 31 Dec 2018 | 3.29m | 4.11% |
| SSgA Funds Management, Inc.as of 31 Dec 2018 | 3.00m | 3.75% |
| Renaissance Technologies LLCas of 31 Dec 2018 | 2.52m | 3.15% |
| Wellington Management Co. LLPas of 31 Dec 2018 | 2.07m | 2.59% |
| Polen Capital Management LLCas of 31 Dec 2018 | 1.71m | 2.14% |
| Fidelity Management & Research Co.as of 31 Dec 2018 | 1.64m | 2.06% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2018 | 1.07m | 1.34% |
| Geode Capital Management LLCas of 31 Dec 2018 | 1.06m | 1.32% |
More ▼
Data from 31 Dec 2018 - 31 Dec 2018Source: FactSet Research Systems Inc.
